Total Payments
$47,608
2024 Payments
$439.65
Companies
19
Transactions
57
Medicare Patients
1,581
Medicare Billing
$162,720
Payment Breakdown by Category
Consulting$37,645 (79.1%)
Other$4,544 (9.5%)
Food & Beverage$2,781 (5.8%)
Travel$2,638 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,645 | 12 | 79.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,544 | 1 | 9.5% |
| Food and Beverage | $2,781 | 33 | 5.8% |
| Travel and Lodging | $2,638 | 11 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $38,150 | 24 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $7,680 | 11 | $0 (2022) |
| Novo Nordisk Inc | $359.35 | 3 | $0 (2024) |
| Amgen Inc. | $246.62 | 2 | $0 (2019) |
| Balt USA, LLC | $241.23 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $221.92 | 2 | $0 (2019) |
| Allergan Inc. | $133.91 | 1 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| HISTOSONICS,INC. | $117.39 | 1 | $0 (2024) |
| Shire North American Group Inc | $71.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $439.65 | 6 | Novo Nordisk Inc ($236.94) |
| 2023 | $225.92 | 2 | Novo Nordisk Inc ($122.41) |
| 2022 | $1,963 | 3 | E.R. Squibb & Sons, L.L.C. ($1,825) |
| 2020 | $2,361 | 1 | E.R. Squibb & Sons, L.L.C. ($2,361) |
| 2019 | $291.57 | 4 | Amgen Inc. ($121.62) |
| 2018 | $3,947 | 13 | E.R. Squibb & Sons, L.L.C. ($3,494) |
| 2017 | $38,380 | 28 | GENZYME CORPORATION ($38,150) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $117.39 | General |
| 07/09/2024 | Stryker Corporation | SPY-PHI SYSTEM (Device) | Food and Beverage | In-kind items and services | $43.58 | General |
| Category: ENDOSCOPY | ||||||
| 02/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.72 | General |
| Category: Obesity | ||||||
| 02/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.22 | General |
| Category: Obesity | ||||||
| 02/13/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 03/22/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $122.41 | General |
| 01/16/2023 | Balt USA, LLC | Prestige Coil System (Device) | Food and Beverage | In-kind items and services | $103.51 | General |
| Category: Neurology | ||||||
| 12/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| 09/25/2022 | Balt USA, LLC | Prestige Coil System (Device) | Food and Beverage | In-kind items and services | $137.72 | General |
| Category: Neurology | ||||||
| 04/26/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 07/02/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,361.00 | General |
| 10/17/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: Neuroscience | ||||||
| 05/07/2019 | Olympus America Inc. | ThunderBeat (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Surgical Energy Products | ||||||
| 04/28/2019 | Avinger Inc. | PANTHERIS (Device) | Food and Beverage | Cash or cash equivalent | $44.35 | General |
| Category: VASCULAR | ||||||
| 03/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $104.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2018 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 11/29/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $71.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $721.34 | General |
| 11/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $90.00 | General |
| 11/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $64.95 | General |
| 11/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 11/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.05 | General |
| 11/12/2018 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $248.48 | General |
| 10/17/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 576 | 635 | $432,203 | $62,157 |
| 2022 | 10 | 443 | 473 | $325,435 | $47,682 |
| 2021 | 9 | 359 | 363 | $248,645 | $38,115 |
| 2020 | 5 | 203 | 207 | $89,926 | $14,766 |
Total Patients
1,581
Total Services
1,678
Medicare Billing
$162,720
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 145 | 145 | $123,105 | $21,634 | 17.6% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2023 | 14 | 14 | $77,605 | $10,775 | 13.9% |
| 64716 | Release and/or relocation of cranial nerve | Facility | 2023 | 29 | 45 | $111,960 | $10,232 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 62 | 72 | $32,976 | $5,287 | 16.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 203 | 231 | $29,568 | $5,223 | 17.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2023 | 44 | 47 | $16,074 | $2,882 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 20 | $13,480 | $2,419 | 17.9% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2023 | 35 | 36 | $9,108 | $1,845 | 20.3% |
| 36500 | Insertion of tube into vein with collection of blood sample | Facility | 2023 | 14 | 14 | $11,452 | $1,047 | 9.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $6,875 | $812.10 | 11.8% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2022 | 15 | 15 | $77,498 | $11,205 | 14.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 65 | 65 | $56,225 | $10,020 | 17.8% |
| 64716 | Release and/or relocation of cranial nerve | Facility | 2022 | 19 | 28 | $69,832 | $6,402 | 9.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 56 | 56 | $35,672 | $6,100 | 17.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2022 | 152 | 167 | $21,877 | $3,891 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 43 | $19,952 | $3,326 | 16.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2022 | 46 | 48 | $16,656 | $2,984 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 14 | $9,632 | $1,459 | 15.1% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2022 | 22 | 22 | $5,566 | $1,149 | 20.6% |
| 36500 | Insertion of tube into vein with collection of blood sample | Facility | 2022 | 15 | 15 | $12,525 | $1,147 | 9.2% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2021 | 17 | 17 | $95,775 | $12,717 | 13.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 58 | 58 | $51,967 | $9,299 | 17.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 50 | 50 | $32,912 | $5,440 | 16.5% |
| 76536 | Ultrasound of head and neck | Facility | 2021 | 133 | 136 | $18,457 | $3,183 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 23 | $11,132 | $1,931 | 17.3% |
About Dr. Melanie Goldfarb, MD
Dr. Melanie Goldfarb, MD is a Surgical Oncology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306092564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melanie Goldfarb, MD has received a total of $47,608 in payments from pharmaceutical and medical device companies, with $439.65 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($37,645).
As a Medicare-enrolled provider, Goldfarb has provided services to 1,581 Medicare beneficiaries, totaling 1,678 services with total Medicare billing of $162,720. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Other Specialties Surgery
- Location Santa Monica, CA
- Active Since 08/07/2008
- Last Updated 02/13/2024
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1306092564
Products in Payments
- DISEASE STATE (Drug) $28,286
- THYROGEN (Drug) $9,864
- Prestige Coil System (Device) $241.23
- Wegovy (Drug) $236.94
- BOTOX OAB (Drug) $133.91
- INTRAROSA (Drug) $125.00
- Prolia (Biological) $125.00
- Aimovig (Biological) $121.62
- TAGRISSO (Drug) $117.65
- IMFINZI (Drug) $104.27
- NATPARA (Drug) $71.47
- SPY Technology (Device) $55.00
- PANTHERIS (Device) $44.35
- SPY-PHI SYSTEM (Device) $43.58
- PROVENGE (Drug) $40.89
- Crysvita (Drug) $21.75
- ThunderBeat (Device) $21.33
- ADSTILADRIN (Biological) $19.99
- Checkpoint Stimulators (Device) $13.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Santa Monica
Dr. Alexander Christ, M.d, M.D
Surgical Oncology — Payments: $137,292
Surgical Oncology $137,292
Alice Chung, M.d, M.D
Surgical Oncology — Payments: $5,396
Surgical Oncology $5,396
Dr. Victoria O'connor, M.d, M.D
Surgical Oncology — Payments: $1,474
Surgical Oncology $1,474
David Leff, Md, MD
Surgical Oncology — Payments: $819.38
Surgical Oncology $819.38